The DistaSense VITALS Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorLife Detection Technologies

About this trial

A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.

Eligibility criteria

Qualifiers

Age ≥ 22 years

Fluent in English

Willing and cognitively able to provide informed consent

BMI < 36

Disqualifiers

Pregnant

Sufficiently broken, damaged or irritated skin or rashes near the sensor application sites such that investigator believes should be precluded from enrollment

Subjects with electronic implants of any kind (e.g. pacemaker)

Subjects that are Life Detection Technology employees or shareholders, or family of a Life Detection Technology employee or shareholder

Trial design

Treatments tested in this trial

  • DistaSense and Polysomnography

Treatment groups

No treatment groups listed

Sponsors and collaborators

Life Detection Technologies

Lead sponsor

Nilo Medical Consulting Group

Collaborator